Quotient Clinical reports another successful year of record growth
7 May 2015 | By kdm communications
Operating capacity set to more than double in response to rising demand...
List view / Grid view
7 May 2015 | By kdm communications
Operating capacity set to more than double in response to rising demand...
22 April 2015 | By kdm communications
Quotient Clinical, the Translational Pharmaceutics® Company, has announced the publication of results from an Enabled-First-in-Human (Enabled-FIH) program conducted for the Janssen WAVE Early Development unit...
31 March 2015 | By Quotient Clinical
Quotient Clinical, the Translational Pharmaceutics® Company, has announced contract wins for three further OncoADME programs to support clinical mass balance/ADME investigations in cancer patients...
21 January 2015 | By kdm communications
Quotient Clinical, the Translational Pharmaceutics® Company, and Sunesis Pharmaceuticals have announced the initiation of a clinical mass balance/ADME trial for vosaroxin – a candidate therapeutic for acute myelogenous leukemia (AML)...
30 September 2014 | By kdm communications
Quotient Clinical, the Translational Pharmaceutics™ company, will present the third annual RapidFACT™ (Rapid Formulation development And Clinical Testing) User Group Meeting...
24 September 2014 | By kdm communications
Quotient Clinical, the Translational Pharmaceutics Company, will present a symposium and three poster publications at the forthcoming 19th North American ISSX Meeting / 29th JSSX Meeting (ISSX/JSSX 2014) from October 19th to 23rd in San Francisco, USA...
7 May 2014 | By kdm communications
Quotient Clinical has announced the extension of its Translational Pharmaceutics™ platform into patient-focused cancer drug development...
7 February 2014 | By kdm communications
Quotient Clinical has commenced its 50th RapidFACT (Rapid Formulation development And Clinical Testing) program – a significant milestone in the development of this service...
11 December 2013 | By KDM Communications
Quotient Clinical has been acquired from the Quotient Bioresearch Group by Bridgepoint Development Capital for an undisclosed sum...
6 November 2013 | By kdm communications limited
Quotient Clinical – the pioneer of Translational Pharmaceutics™ – will be showcasing the benefits of its unique, integrated approach to formulation development...
3 March 2011 | By The Scott Partnership
To accommodate demand for its RapidFACT Service...
10 November 2010 | By The Scott Partnership
Speeding the advance of compounds to clinical trials and expanding options for drug delivery...